E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.

Saved in:
Bibliographic Details
Title: E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Authors: Connolly RM; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Cancer Research at UCC, College of Medicine and Health, University College Cork, Cork, Ireland., Zhao F; Dana-Farber Cancer Institute, Boston, MA., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN., Lee MJ; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Piekarz RL; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Smith KL; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Brown-Glaberman UA; University of New Mexico Cancer Center, Albuquerque, NM., Winn JS; Fox Chase Cancer Center, Philadelphia, PA., Faller BA; Heartland NCORP, Missouri Baptist Medical Centre, Saint Louis, MO., Onitilo AA; Marshfield Clinic, Marshfield, WI., Burkard ME; University of Wisconsin Carbone Cancer Center, Madison, WI., Budd GT; Cleveland Clinic Foundation, Cleveland, OH., Levine EG; Roswell Park Cancer Institute, Buffalo, NY., Royce ME; New Mexico MU-NCORP, Albuquerque, NM., Kaufman PA; University of Vermont Cancer Center, Burlington, VT., Thomas A; Wake Forest University, Winston Salem, NC., Trepel JB; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wolff AC; The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Sparano JA; Montefiore Medical Center, New York, NY.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 01; Vol. 39 (28), pp. 3171-3181. Date of Electronic Publication: 2021 Aug 06.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.21.00944